FTE CAPITAL · BOUTIQUE INVESTMENT BANK
FTE Capital combines industry insight, capital strategy and transaction execution to support exceptional healthcare and AI-for-science entrepreneurs through pivotal transactions.
An embedded advisory partner for founders building category-defining companies.
FTEC stands for Filter, Transition and Evolution — a philosophy of selecting signal, shaping transformation and compounding enterprise value.
FTE Capital is a boutique investment bank focused on healthcare and AI for science. We believe pivotal transactions are not merely matched; they are shaped by industry judgement, capital strategy and disciplined execution.
Four pivotal investment banking practices
Research-led judgement and execution discipline across financing, equity transactions, M&A and BD / licensing.
From equity story and materials to investor targeting and negotiation, we help companies complete high-quality private financings.
We structure secondary and strategic equity transactions that balance pricing, shareholder alignment and long-term value.
We design transaction pathways between buyers and sellers, from target screening and valuation to negotiation and capital-market follow-through.
We support product rights, upstream / downstream partnerships and cross-border BD transactions from counterparty search to commercial terms.
Healthcare and AI for Science
We focus on sectors where interdisciplinary judgement and capital-market articulation matter most.
Coverage across innovative therapeutics, medical devices, diagnostics, life-science tools, digital health and healthcare services.
Focused on AI-enabled drug discovery, protein design, R&D automation, scientific infrastructure and productivity transformation.
Banking, investing and industry experience
Research-led transaction judgement
AI for Science
The capital value of an AI-for-science company rests on three linked narratives: whether algorithms and proprietary data create a verifiable technical edge, whether scientific output converts into a defined product and commercial pathway, and whether the platform can repeatedly generate partnerships, pipeline assets or revenue. A credible financing case connects technology, industry outcomes and valuation through measurable milestones.
BD
A research framework around product rights, clinical milestones, commercial certainty and deal structure.
Founder transition
The transition from scientist to entrepreneur is not simply a change in title; it requires sharper strategic focus, deliberate organization building and a redesigned capital cadence. At pivotal stages, an investment banking partner should clarify the company's value narrative, align it with patient capital and translate R&D milestones into executable financing and industry-partnership pathways.
Start a conversation with us
Beijing · Shanghai | contact@fte-capital.com
